Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 501-509

  Bacaksiz, Ahmet ^a   Erdogan, Ercan ^a   Sonmez, Osman ^a   Sevgili, Emrah ^a   Tasal, Abdurrahman ^a   Onsun, Nahide ^a   Topukcu, Bugce ^a   Kulaç, Beytullah ^a   Uysal, Omer ^a   Goktekin, Omer ^a  

^a Bezmialem Foundation University   (Turkey)

Author keywords

Ambulatory; Blood pressure monitoring; Hypertension cardiovascular risk; Masked hypertension; Psoriasis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY SURFACE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MORBIDITY; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; SEX DIFFERENCE; SMOKING; SPHYGMOMANOMETRY; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASKED HYPERTENSION; PREVALENCE; PSORIASIS; TURKEY; YOUNG ADULT;

EID: 84879564308     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889197     Document Type: Article

References (42)

1. Schon MP, Boehncke WH: Psoriasis. N Engl J Med, 2005; 352: 1899-912
2. Acikbas I, Sanli B, Tepeli E et al: Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patients. Med Sci Monit, 2012; 18(11): CR661-66
3. Prodanovich S, Kirsner RS, Kravetz JD et al: Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol, 2009; 145: 700-3
4. Rosa DJ, Machado RF, Matias FA et al: Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis. J Eur Acad Dermatol Venereol, 2012; 26: 348-53
5. Markuszeski L, Bissinger A, Janusz I et al: Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res, 2007; 38: 64-69
6. Ahlehoff O, Gislason GH, Jorgensen CH et al: Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J, 2012; 33: 2054-64
7. Krzesiński P, Gielerak GG, Kowal JJ: A "patient-tailored" treatment of hypertension with use of impedance cardiography: A randomized, prospective and controlled trial. Med Sci Monit, 2013; 19: 242-50
8. Sommer DM, Jenisch S, Suchan M et al: Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res, 2006; 298: 321-28
9. Zindanci I, Albayrak O, Kavala M et al: Prevalence of metabolic syndrome in patients with psoriasis. Scientific World Journal, 2012; 2012: 312463
10. Dauden E, Castaneda S, Suarez C et al: [Integrated approach to comorbidity in patients with psoriasis]. Actas Dermosifiliogr, 2012; 103(Suppl.1): 1-64
11. Pickering TG, Hall JE, Appel LJ et al: Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation, 2005; 111: 697-716
12. Bjorklund K, Lind L, Zethelius B et al: Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation, 2003; 107: 1297-302
13. Bobrie G, Chatellier G, Genes N et al: Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA, 2004; 291: 1342-49
14. Ohkubo T, Kikuya M, Metoki H et al: Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol, 2005; 46: 508-15
15. Liu JE, Roman MJ, Pini R et al: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med, 1999; 131: 564-72
16. Sega R, Trocino G, Lanzarotti A et al: Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation, 2001; 104: 1385-92
17. Imai Y, Tsuji I, Nagai K et al: Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese community. Hypertens Res, 1996; 19: 207-12
18. Palatini P, Winnicki M, Santonastaso M et al: Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage I hypertension. Hypertension, 2004; 44: 170-74
19. Selenta C, Hogan BE, Linden W: How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med, 2000; 9: 533-40
20. Palatini P: Masked hypertension: how can the condition be detected? Blood Press Monit, 2004; 9: 297-99
21. Louden BA, Pearce DJ, Lang W, Feldman SR: A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J, 2004; 10: 7
22. Amornpinyokeit N, Asawanonda P: 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. Photodermatol Photoimmunol Photomed, 2006; 22: 285-89
23. Rich P, Scher RK: Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol, 2003; 49: 206-12
24. Madin K, Iqbal P: Twenty four hour ambulatory blood pressure monitoring: a new tool for determining cardiovascular prognosis. Postgrad Med J, 2006; 82: 548-51
25. O'Brien E, Asmar R, Beilin L et al: Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens, 2005; 23: 697-701
26. Soylu A, Yazici M, Duzenli MA et al: Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ J, 2009; 73: 899-904
27. Bacaksiz A, Akif Vatankulu M, Sonmez O et al: Non-dipping nocturnal blood pressure in psoriasis vulgaris. Wien Klin Wochenschr, 2012; 124(23-24): 822-29
28. Armstrong AW, Lin SW, Chambers CJ et al: Psoriasis and hypertension severity: results from a case-control study. PLoS One, 2011; 6: e18227
29. Flammer AJ, Ruschitzka F: Psoriasis and atherosclerosis: two plaques, one syndrome? Eur Heart J, 2012; 33: 1989-91
30. Cymerys M, Bogdański P, Pupek-Musialik D et al: Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension. Med Sci Monit, 2012; 18(5): CR330-36
31. Haligur BD, Cicek D, Bulut S, Berilgen MS: The investigation of autonomic functions in patients with psoriasis. Int J Dermatol, 2012; 51: 557-63
32. Ena P, Madeddu P, Glorioso N et al: High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol, 1985; 40: 199-205
33. Boehncke WH, Boehncke S: Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences. G Ital Dermatol Venereol, 2008; 143: 307-513
34. Enany B, El Zohiery AK, Elhilaly R, Badr T: Carotid intima-media thickness and serum leptin in psoriasis. Herz, 2012; 37: 527-33
35. Gisondi P, Fantin F, Del Giglio M et al: Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology, 2009; 218: 110-13
36. Pierdomenico SD, Cuccurullo F: Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. Blood Press Monit, 2010; 15: 1-7
37. Pickering TG, Davidson K, Gerin W, Schwartz JE: Masked hypertension. Hypertension, 2002; 40: 795-96
38. Longo D, Dorigatti F, Paratini P: Masked hypertension in adults. Blood Press Monit, 2005; 10: 307-10
39. Kawano Y, Horio T, Matayoshi T, Kamide K: Masked Hypertension: Subtypes and Target Organ Damage. Clin Exp Hypertens, 2008; 30: 289-96
40. Asayama K, Sato A, Ohkubo T et al: The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study. Hypertens Res, 2009; 32: 438-43
41. Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H: Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens, 1998; 16: 1415-24
42. Mancia G, Sega R, Bravi C et al: Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens, 1995; 13: 1377-90